$1.15 Million Vision Award Goes to Scientists Who Helped Develop Luxturna

September 7, 2018: By Joan McKenna

Seven scientists who contributed to the development of Spark Therapeutics’ Luxturna (voretigene neparvovec-rzyl) for the treatment of Leber congenital amaurosis have been honored with a $1.15 million vision award by Portugal’s Champalimaud Foundation, the group announced Sept. 4.

The scientists are:

–Jean Bennett , MD, PhD, and Albert M. Maguire, MD, Scheie Eye Institute, University of Pennsylvania School of Medicine and Children’s Hospital of Philadelphia;

–Robin Ali, PhD, and James Bainbridge MD, PhD, Institute of Ophthalmology of the University College London and Moorfields Eye Hospital;

–Samuel G. Jacobson, MD, PhD, and William W. Hauswirth, PhD, Scheie Eye Institute, University of Pennsylvania School of Medicine and University of Florida College of Medicine;

–Michael Redmond, PhD, chief of the National Eye Institute (NEI) Laboratory of Retinal Cell and Molecular Biology, whose work in discovering the genetic cause of the disease laid the foundation for the work of the others.

The António Champalimaud Vision Award was launched in 2006 and is considered among the most prestigious vision science prizes, according to the NEI.

Redmond’s award will be given to the NEI in support of his research, the institute said.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Carl Zeiss Meditec Announces Milestone of 1.5 Million SMILE Procedures

Heidelberg Gains US Clearance for OCT Angiography Module

ASCRS Convenes Task Force to Study CyPass Data, Make Recommendations

Bascom Palmer Treats First US Patient in Nightstar’s Trial for X-Linked Retinitis Pigmentosa

First Patient Treated in Allotex’ Trial for Allogenic Refractive Lenticules for Presbyopia

Bausch + Lomb Announces Positive Results for Loteprednol Etabonate Gel

LumiThera Set to Launch Valeda Light Delivery System for Dry AMD

Kodiak Sciences Names Jason Ehrlich, MD, PhD, Chief Medical Officer

Second Sight Receives $1.6 Million Grant from NIH to Support Orion Program

Regeneron to Invest $800 Million in New York Campus

American Women Raise Funds for Nepal Mission to Reduce Corneal Blindness

Ziemer to Add Lenticule Extraction Capabilities to LDV Z8

Stealth BioTherapeutics Raises $100 Million in Support of Elamipretide for Dry AMD

STAAR Gains US Approval of Visian Toric ICL

Sun Pharma, SPARC Announce FDA Approval for Xelpros for Open-Angle Glaucoma, Ocular Hypertension

FDA Will Review Regeneron’s Submission to Expand Eylea’s Labeling to All DR Patients

Alcon Will Locate Headquarters in Switzerland

Kodiak Sciences Files for $100 Million IPO

Iridex Announces $10 Million Public Offering

Oxford BioMedica Expands Capacity with New Facility

Coming soon

2018 Ophthalmic Deals Book: Venture Funding, Commercial Equity, and Business/Technology Sales